在接受布普伦诺芬治疗阿片类药物使用障碍的妇女中,患者报告了对睡眠干预的偏好
Michelle Eglovitch1, Anna Beth Parlier-Ahmad1, Catherine Legge2
1Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States.
Frontiers in psychiatry
|October 2, 2023
概括
接受阿片类药物使用障碍 (MOUD) 治疗的女性希望灵活的失眠治疗,包括药物和行为选择,以满足他们的康复需求.
科学领域:
- 成 药物 药物 药物 药物
- 睡眠科学 睡眠科学
- 妇女健康 妇女健康
背景情况:
- 失眠在治疗阿片类药物使用障碍 (MOUD) 的药物中很常见,恶化了OUD的结果.
- 在OUD患者中,患者对失眠治疗的偏好尚不清楚.
研究的目的:
- 探索患者报告的OUD治疗中妇女对睡眠干预的偏好.
- 在这个人群中调查失眠治疗的可接受性和理想特征.
主要方法:
- 一个正在进行的横截面调查和面试研究的混合方法分析.
- 包括不怀孕的妇女 (18-45岁) 服用布普伦诺芬.
- 使用失眠严重性指数 (ISI) 和半结构面试对失眠的评估,以获得定性见解.
主要成果:
- 定性访谈揭示了睡眠治疗的各种经验.
- 参与者希望灵活的睡眠干预措施,适应诸如照顾等社会决定因素.
- 偏好包括药理和行为选择,优先考虑非镇静性,非成性药物.
结论:
- 接受MOUD治疗的女性经常患有失眠症,并寻求综合药理和行为睡眠干预措施.
- 基于证据的睡眠策略必须考虑独特的社会环境因素,影响OUD恢复中的女性的实施.
相关概念视频
Substance Use Disorders Affecting Sleep
188
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
188
Sedatives and Hypnotics Drugs: Miscellaneous Agents
196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196
Management of Insomnia
274
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
274
CNS Depressants: Barbiturates and Benzodiazepines
303
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
303
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326
Sedatives and Hypnotics: Overview
428
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
428


